Food Animal Med. Exam I Flashcards
Point of Balance
at animal’s shoulder
blind spot
directly behind animal
arched back indicates
lame, chest or belly pain
BCS dairy
5
3 is ideal
BCS beef
9
5 is ideal
urine collection
rub escuthcheon
urine pH
7-9
adult temp
100.5-102.5 F
calf
101.5- 103 F
adult HR
60-80 beats/min
calf HR
100-140 beats/min
adult RR
12-36 breaths/min
calf RR
30-60 breaths/min
absence of lung sounds means
consolidation, pneumothorax, or pleural effusion
what cause ping on percussion
fluid-gas interface
LDA pings
between 12 and 13th ribs
rumen contraction rate
1-3 contractions/min
withers pinch test
normal cows will ventroflex
painful cows refuse to ventroflex
grunt test
upward pressure in xyphoid region
painful animal has + test-> grunt, kick, act uncomfortable
ear discharge
likely Mycoplasma infection
cold ear indicates
hypocalcemia or sepsis
central incisors
fully developed 2 years
permanent first intermediate incisors
3 years
permanent second intermediate incisors
4 years
full development all incisors
5-6 years
exponential decay of drugs in body
first order kinetics
present for long time at low concentrations
withdrawal time
time until drug levels in edible tissues deplete to safe levels
start when last dose is given
NOEL
no observable effect level
oral dose that results in no toxic effects in test animals
done in 2 different lab animals and extrapolated to humans
ADI
acceptable daily intake
NOEL translated into ADI (NOEL/1000 safety factor)
total dose of drug that an average human could ingest on a daily basis for his/her entire life w/ no AE
AE
acute toxicity
microbiological effects
carcinogenicity
teratogenicity
Safety factors
interspecies extrapolation
sensitive subpopulations
long term exposures
multiples of 10-> make NOEL 1000x lower
safe concentration
allowable amount of drug in each of edible tissues
how much can be in meat so person eating won’t go over ADI
ADI/ food consumption factor
parent compound + metabolites
tolerance
allowable concentration of marker residue in edible tissues
what FDA tests for- either metabolite or parent compound (1 compound- the marker residue)
target tissue
tissue from which marker residue depletes the slowest
usually liver or kidneys
what is tested
safe concentration x proportion of maker residue
withdrawal time
Time for marker residue in target tissue to deplete to concentrations below the tolerance
withdrawal time cont.
Time needed for 99th percentile of population to deplete to tolerance with 95% confidence
extralabel drug use
dose route of administration duration of treatment volume per injection site species
half life changes
w/ change in route of administration
double half life double withdrawal time
dose changes
add one half life for every doubling of initial concentration
ELDU allowed
only if enough information is available to calculate an extended withdrawal interval
FARAD
food animal residue avoidance databank
AMDUCA
animal medicinal drug use clarification act
legalizes ELDU in vet med
places constraints on ELDU
ELDU
must write own label every time
can’t put in feed
economic reasons not enough to go ELDU
compounding highly restricted
cattle pain management
not many approved drugs - ELDU
cost prohibitive due to large volumes needed
cox-2 specific inhibitors
etodolac and carprofen
possible increased safety for chronic administration (abomasal ulcers)
morphine
epidural anesthesia
parenteral
butorphanol
meperidine
buprenorphine
alpha 2 agonist (xylazine)
epidural
parenteral- sedation
reversible
susceptible to AE- small relative doses (different than dogs!!)
impt drug considerations
therapeutic objectives
economic considerations
ease of administration
potential for violative residues
major species
cattle, swine, chickens, turkeys, dogs, cats, horses
minor species
sheep, goats, small mammals, reptiles, birds, fish, camelids, deer, etc.
greater flexibility in drug approval requirements
data extrapolation
alternative sources of data
compliance policy guide 615.115
FDA’s direction to field investigators to exercise enforcement discretion in cases of ELDU of medicated feeds in minor species
won’t enforce ELDU in feed very much b/c none approved on label for this and need sometimes
MUMS act
minor use and minor species animal health act
passed 2004
encourages companies to seek regulatory approval for drugs for MUMS
MUMS cont.
conditional approval up to 5 years (need safety data and continue collect effectiveness data)
indexing- unapproved drugs can be legally marketed towards MUMS
incentives to companies
NRSP-7
national research support project no. 7
funds grants for research for FDA approval studies by researches/producers that companies can then use for approval
research public information
interspecies scaling done by
basal metabolic rate
rules of thumb
higher doses (mg/kg) and shorter withdrawal intervals in sheep/goat compared to cattle
more predictable: water soluble minimally metabolized drugs
less predictable: lipid soluble highly metabolized drugs
conjunctiva chemosis (swelling)
from hypoproteinemia from Haemonchus contortus in sheep
conjunctiva hemorrhage
coagulopathies or septicemia
microphthalmia
small globe
staphylomas
outpouching of eye
teratogenic agents
Veratum californicum (false helibore, skunk cabbage)
consumed plant alkaloids day 14 only
cyclopia, synophthalomos, anopthalmos (absence of eyes)
synophthalmia
2 eyes but share a fissure and orbit
blepharitis
inflammation/swelling of eyelids
blepharospasms
Blinks frequently and doesn’t hold eye open all the way
nystagmus
shifting left to right or dorsally/ventrally of eye
enopthalmos
posterior displacement of eye- retraction of globe in orbit
profound dehydration #1 cause
emaciation
ptosis
falling/drooping of upper/lower eyelid
micropalpebral fissure
abnormally small or narrow eyelid opening
strabismus
eyes do not line up–> “cross eyed”
entropion
eyelid inversion
keratitis
inflammation of cornea
cicatricial
scarring (eyelid laceration never corrected)
Sarcoptes scabiei
reportable in ruminants
keratoconjunctivitis
inflammation of cornea and conjunctiva
Chlamydophila pecorum type 2 and Mycoplasma sp. impt.
epiphera
tearing